A Rockville-based research and development company working on a cheap and fast diagnostic test for infectious diseases will be the first tenant of Inova Health System’s new accelerator that officially opened Thursday.
When the 13 teams that made up Fed Tech’s fall 2017 cohort took the stage for their first pitch night in September, it wasn’t entirely smooth sailing.
The entrepreneurs, some of whom had been introduced to their assigned technology just days earlier, struggled to pronounce long scientific words or, in some cases, explain what the technology is at all. The task wasn’t easy, but the entrepreneurs didn’t get a pass either. “You gotta tell me what you do,” the group of rowdy mentors lobbed at one team. “Tell me who cares.”
A reindeer with a red glowing nose.
A heart, two sizes two small, that suddenly grows three sizes.
A trip to the past and to the future — all in one night.
Steve Case’s Rise of the Rest seed fund has raised $150 million from a cavalcade of high-profile investors.
Investors in the new fund, named after Case’s yearslong effort to draw more attention to nontraditional areas outside of Silicon Valley and New York, include Amazon chief and Washington Post owner Jeff Bezos, The Carlyle Group co-founder David Rubenstein, Google CEO Eric Schmidt, Starbucks CEO Howard Schultz and members of the Koch, Pritzker and Walton families, according to a release.
The landscape for the delivery of health care in the United States is changing, but the traditional care-delivery players are not the change agents. The recent announcement of CVS’s $69 billion deal to acquire Aetna brings an insurer together with a large network of primary care providers: CVS has built more than 1,100 Minute Clinic locations inside its pharmacy stores in 33 states and the District of Columbia.
Johnson & Johnson Innovation, today announced a collaboration with the Shanghai Municipal Government, Pudong New Area Government, and Shanghai Pharma Engine Company, Ltd. to launch a new Johnson & Johnson Innovation, JLABS in Shanghai (JLABS @ Shanghai), China. The 4,400-square-meter facility will be located in Shanghai’s Zhangjiang Hi-Tech Park and will open in Q2 2019.
The Maryland Technology Development Corp. announced $800,000 in investments to six companies, including four in the Baltimore area.
State-backed TEDCO funnels hundreds of thousands of dollars into young, growing companies through its multiple investment funds and is backed by an annual budget of about $18.5 million. The organization’s seed fund portfolio continues to grow statewide.
The Inova Personalized Health Accelerator opened its doors on Wednesday, with a ribbon cutting attended by over 300 guests. Rockville, Md.–based HeMemics was named as the first of six health technology startups that the hospital system will invest in its portfolio by the second quarter of next year.
Towson University officials are envisioning the college’s new $184 million science building as essentially the exact opposite of Smith Hall, the building that currently holds most of Towson’s science classes.
Inova Personalized Health Accelerator (IPHA) has selected HeMemics Biotechnologies, Inc. (HBI) as its first portfolio company. HBI is a research and development company located in Rockville, MD that develops rapid diagnostic test platforms to detect various bacterial and viral pathogens. The company’s technology detects, within 15 seconds, the absence or presence of a specific virus or bacterium when an aqueous sample is placed on an electronic chip. HeMemics invented and patented “HemSol™,” a method to preserve cells and biological entities for an extended period of time. The preservation method in conjunction with the low cost HeMemics prototype electronic chip and portable, battery-powered reading device are designed to be deployed for Point of Care (POC) diagnostics. Typically, pathogen detection involves laboratory analysis which delays inpatient treatment or requires a return visit for outpatients.